Clinical Trial Update: Evaluation of AP-002 in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating AP-002 in patients with solid tumors is ongoing, with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• AP-002

Snippet

Sponsor: Altum Pharmaceuticals INC | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN